In thyroid cancer, CTNNBIP1 functions as a negative regulator of the Wnt/β-catenin pathway by decreasing the interaction between β-catenin and TCF/LEF to inhibit the expression of downstream target proteins. The gene discussed is HNF4A; the disease is thyroid gland carcinoma.